世界の皮膚糸状菌症用薬市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A2928)
◆英語タイトル:Global Drugs for Dermatophytosis Sales Market Report 2019
◆商品コード:DATA907A2928
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月(※2024年版があります。お問い合わせください。)
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、皮膚糸状菌症用薬の世界市場について調査・分析し、皮膚糸状菌症用薬のメーカー別販売量、市場シェア分析、種類別販売分析(Rx、OTC)、用途別販売分析(Hospital、Clinic、Other)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・皮膚糸状菌症用薬市場概要
・皮膚糸状菌症用薬のメーカー別販売量・メーカー別シェア
・皮膚糸状菌症用薬の種類別販売量(Rx、OTC)
・皮膚糸状菌症用薬の用途別販売量(Hospital、Clinic、Other)
・皮膚糸状菌症用薬の地域別販売量・市場シェア
・皮膚糸状菌症用薬のアメリカ市場規模(2014年-2019年)
・皮膚糸状菌症用薬のヨーロッパ市場規模(2014年-2019年)
・皮膚糸状菌症用薬の中国市場規模(2014年-2019年)
・皮膚糸状菌症用薬の日本市場規模(2014年-2019年)
・皮膚糸状菌症用薬の東南アジア市場規模(2014年-2019年)
・皮膚糸状菌症用薬のインド市場規模(2014年-2019年)
・皮膚糸状菌症用薬メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・皮膚糸状菌症用薬のコスト分析
・皮膚糸状菌症用薬販売チャネル、流通業者、顧客
・皮膚糸状菌症用薬の世界市場動向・機会・成長要因・課題
・皮膚糸状菌症用薬の種類別世界市場予測(Rx、OTC)
・皮膚糸状菌症用薬の用途別世界市場予測(Hospital、Clinic、Other)
・皮膚糸状菌症用薬のアメリカ市場予測(2019年-2025年)
・皮膚糸状菌症用薬のヨーロッパ市場予測(2019年-2025年)
・皮膚糸状菌症用薬の中国市場予測(2019年-2025年)
・皮膚糸状菌症用薬の日本市場予測(2019年-2025年)
・皮膚糸状菌症用薬の東南アジア市場予測(2019年-2025年)
・皮膚糸状菌症用薬のインド市場予測(2019年-2025年)
...
【レポートの概要】

Ringworm on the skin like athlete’s foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.
The global Drugs for Dermatophytosis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Drugs for Dermatophytosis market status and forecast, categorizes the global Drugs for Dermatophytosis market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rx
OTC

Segment by Application
Hospital
Clinic
Other

【レポートの目次】

Table of Contents

Global Drugs for Dermatophytosis Sales Market Report 2019
1 Drugs for Dermatophytosis Market Overview
1.1 Drugs for DermatophytosisProduct Overview
1.2 Drugs for Dermatophytosis Segment by Type
1.2.1 Global Drugs for Dermatophytosis Sales Comparison by Types (2014-2025)
1.2.2 Rx
1.2.3 OTC
1.3 Drugs for Dermatophytosis Segment by Application
1.3.1 Global Drugs for Dermatophytosis Sales Comparison by Application (2014-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Drugs for Dermatophytosis Market by Region
1.4.1 Global Drugs for Dermatophytosis Revenue Comparison by Region (2014-2025)
1.4.2 United States Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.4.3 Europe Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.4.4 China Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.4.5 Japan Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.4.6 Southeast Asia Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.4.7 India Drugs for Dermatophytosis Status and Prospect (2014-2025)
1.5 Global Drugs for Dermatophytosis Sales and Revenue (2014-2025)
1.5.1 Global Drugs for Dermatophytosis Sales and Growth Rate (2014-2025)
1.5.2 Global Drugs for Dermatophytosis Revenue and Growth Rate (2014-2025)

2 Drugs for Dermatophytosis by Company, Region, Type and Application
2.1 Global Drugs for Dermatophytosis Market Competition by Companies
2.1.1 Global Drugs for Dermatophytosis Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Drugs for Dermatophytosis Revenue Market Share by Company (2014-2019)
2.2 Global Drugs for Dermatophytosis Sales and Revenue by Region
2.2.1 Global Drugs for Dermatophytosis Sales Market Share by Region (2014-2019)
2.2.2 Global Drugs for Dermatophytosis Revenue Market Share by Region (2014-2019)
2.3 Global Drugs for Dermatophytosis Sales and Revenue by Type
2.3.1 Global Drugs for Dermatophytosis Sales Market Share by Type (2014-2019)
2.3.2 Global Drugs for Dermatophytosis Revenue Market Share by Type (2014-2019)
2.4 Global Drugs for Dermatophytosis Sales by Application

3 United States Drugs for Dermatophytosis Sales, Revenue and Price
3.1 United States Drugs for Dermatophytosis Sales and Revenue (2014-2019)
3.1.1 United States Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
3.1.2 United States Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
3.1.3 United States Drugs for Dermatophytosis Price Trend (2014-2019)
3.2 United States Drugs for Dermatophytosis Sales Market Share by Company
3.3 United States Drugs for Dermatophytosis Sales Market Share by Type
3.4 United States Drugs for Dermatophytosis Sales Market Share by Application

4 Europe Drugs for Dermatophytosis Sales, Revenue and Price
4.1 Europe Drugs for Dermatophytosis Sales and Value (2014-2019)
4.1.1 Europe Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
4.1.2 Europe Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
4.1.3 Europe Drugs for Dermatophytosis Price Trend (2014-2019)
4.2 Europe Drugs for Dermatophytosis Sales Market Share by Company
4.3 Europe Drugs for Dermatophytosis Sales Market Share by Type
4.4 Europe Drugs for Dermatophytosis Sales Market Share by Application

5 China Drugs for Dermatophytosis Sales, Revenue and Price
5.1 China Drugs for Dermatophytosis Sales and Revenue (2014-2019)
5.1.1 China Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
5.1.2 China Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
5.1.3 China Drugs for Dermatophytosis Price Trend (2014-2019)
5.2 China Drugs for Dermatophytosis Sales Market Share by Company
5.3 China Drugs for Dermatophytosis Sales Market Share by Type
5.4 China Drugs for Dermatophytosis Sales Market Share by Application

6 Japan Drugs for Dermatophytosis Sales, Revenue and Price
6.1 Japan Drugs for Dermatophytosis Sales and Value (2014-2019)
6.1.1 Japan Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
6.1.2 Japan Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
6.1.3 Japan Drugs for Dermatophytosis Price Trend (2014-2019)
6.2 Japan Drugs for Dermatophytosis Sales Market Share by Company
6.3 Japan Drugs for Dermatophytosis Sales Market Share by Type
6.4 Japan Drugs for Dermatophytosis Sales Market Share by Application

7 Southeast Asia Drugs for Dermatophytosis Sales, Revenue and Price
7.1 Southeast Asia Drugs for Dermatophytosis Sales and Value (2014-2019)
7.1.1 Southeast Asia Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Drugs for Dermatophytosis Price Trend (2014-2019)
7.2 Southeast Asia Drugs for Dermatophytosis Sales Market Share by Company
7.3 Southeast Asia Drugs for Dermatophytosis Sales Market Share by Type
7.4 Southeast Asia Drugs for Dermatophytosis Sales Market Share by Application

8 India Drugs for Dermatophytosis Sales, Revenue and Price
8.1 India Drugs for Dermatophytosis Sales and Value (2014-2019)
8.1.1 India Drugs for Dermatophytosis Sales Growth Rate (2014-2019)
8.1.2 India Drugs for Dermatophytosis Revenue Growth Rate (2014-2019)
8.1.3 India Drugs for Dermatophytosis Price Trend (2014-2019)
8.2 India Drugs for Dermatophytosis Sales Market Share by Company
8.3 India Drugs for Dermatophytosis Sales Market Share by Type
8.4 India Drugs for Dermatophytosis Sales Market Share by Application

9 Company Profiles and Key Figures in Drugs for Dermatophytosis Business
9.1 Novartis
9.1.1 Novartis Drugs for Dermatophytosis Production Sites and Area Served
9.1.2 Drugs for Dermatophytosis Specification and Application
9.1.3 Novartis Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Pfizer
9.2.1 Pfizer Drugs for Dermatophytosis Production Sites and Area Served
9.2.2 Drugs for Dermatophytosis Specification and Application
9.2.3 Pfizer Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Sanofi-Aventis
9.3.1 Sanofi-Aventis Drugs for Dermatophytosis Production Sites and Area Served
9.3.2 Drugs for Dermatophytosis Specification and Application
9.3.3 Sanofi-Aventis Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Merck
9.4.1 Merck Drugs for Dermatophytosis Production Sites and Area Served
9.4.2 Drugs for Dermatophytosis Specification and Application
9.4.3 Merck Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Enzon Pharmaceuticals
9.5.1 Enzon Pharmaceuticals Drugs for Dermatophytosis Production Sites and Area Served
9.5.2 Drugs for Dermatophytosis Specification and Application
9.5.3 Enzon Pharmaceuticals Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Bayer
9.6.1 Bayer Drugs for Dermatophytosis Production Sites and Area Served
9.6.2 Drugs for Dermatophytosis Specification and Application
9.6.3 Bayer Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Astellas Pharma
9.7.1 Astellas Pharma Production Sites and Area Served
9.7.2 Drugs for Dermatophytosis Specification and Application
9.7.3 Astellas Pharma Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 GSK
9.8.1 GSK Drugs for Dermatophytosis Production Sites and Area Served
9.8.2 Drugs for Dermatophytosis Specification and Application
9.8.3 GSK Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Abbott
9.9.1 Abbott Drugs for Dermatophytosis Production Sites and Area Served
9.9.2 Drugs for Dermatophytosis Specification and Application
9.9.3 Abbott Drugs for Dermatophytosis Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served

10 Drugs for Dermatophytosis Maufacturing Cost Analysis
10.1 Drugs for Dermatophytosis Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Drugs for Dermatophytosis
10.4 Drugs for Dermatophytosis Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Drugs for Dermatophytosis Distributors List
11.3 Drugs for Dermatophytosis Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Drugs for Dermatophytosis Market Forecast
13.1 Global Drugs for Dermatophytosis Sales, Revenue and Price Forecast
13.1.1 Global Drugs for Dermatophytosis Sales Growth Forecast (2019-2025)
13.1.2 Global Drugs for Dermatophytosis Revenue Growth Forecast (2019-2025)
13.1.3 Global Drugs for Dermatophytosis Price Trend Forecast (2019-2025)
13.2 Global Drugs for Dermatophytosis Forecast by Region
13.2.1 Global Drugs for Dermatophytosis Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Drugs for Dermatophytosis Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Drugs for Dermatophytosis Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Drugs for Dermatophytosis Forecast by Type
13.3.1 Global Drugs for Dermatophytosis Sales Forecast by Type (2019-2025)
13.3.2 Global Drugs for Dermatophytosis Revenue Forecast by Type (2019-2025)
13.3.3 Global Drugs for Dermatophytosis Price Forecast by Type (2019-2025)
13.4 Global Drugs for Dermatophytosis Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の皮膚糸状菌症用薬市場:販売動向2019(Global Drugs for Dermatophytosis Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。